ANTIBE THERAPEUTICS

Antibe Therapeutics develops novel anti-inflammatory drugs that are improved versions of existing drugs. They focus on diseases characterized by inflammation, pain, and/or vascular dysfunction. Their drug design approach is to create new drugs by improving existing, proven drugs. The company's technology platform enables us to chemically link an existing drug to a hydrogen sulfide-releasing moeity. Hydrogen sulfide (H2S) is one of several so-called gaseous mediators. Gaseous mediators are natu... rally occurring substances found in the human body. Acting as neuromodulators, immunomodulators, and vasodilators, gaseous mediators such as H2S regulate fundamental cellular processes. Antibe believes that H2S has tremendous therapeutic potential. Antibe’s R&D is guided by a leading team of pharmaceutical researchers and advisors. The team includes a Nobel Prize winner, highly successful entrepreneurs, and senior scientists affiliated with major research institutions worldwide.

#SimilarOrganizations #People #Financial #Website #More

ANTIBE THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Medical Therapeutics

Founded:

2010-01-01

Address:

Toronto, Ontario, Canada

Country:

Canada

Website Url:

http://www.antibethera.com

Total Employee:

11+

Status:

Active

Contact:

416-922-3460

Email Addresses:

[email protected]

Total Funding:

71.94 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics